r
c
l
e
n
f
chines
herbal
medicin
huogu
formula
osteonecrosi
femor
head
sar
steroidrel
osteonecrosi
purpos
coronaviru
diseas
remind
us
sever
acut
respiratori
syndrom
sar
outbreak
date
corticosteroid
commonli
administr
sever
patient
osteonecrosi
femor
head
onfh
common
disabl
complic
among
convalesc
sar
patient
receiv
corticosteroid
therapi
china
consider
number
convalesc
sar
patient
steroidassoci
onfh
undergon
conserv
treatment
tradit
chines
medicin
studi
aim
evalu
longterm
result
spleeninvigor
huogu
formula
hgf
therapi
patient
particip
method
total
convalesc
sar
patient
male
femal
bilater
steroidassoci
onfh
hip
enrol
studi
patient
receiv
oral
hgf
therapi
month
confirm
diagnosi
steroidassoci
onfh
regularli
follow
interv
year
harri
hip
score
medic
imag
modal
includ
plain
radiographi
comput
tomographi
magnet
reson
imag
perform
evalu
outcom
result
base
averag
year
followup
hgf
therapi
rang
year
hip
among
hip
develop
definit
osteoarthr
hip
precollaps
hip
associ
research
circul
osseou
arco
stage
ii
progress
femor
head
collaps
arco
stage
iii
iv
five
patient
also
hip
underw
total
hip
arthroplasti
mean
hip
surviv
time
year
kaplanmei
analysi
observ
mean
harri
hip
score
point
repres
reserv
pain
score
physic
function
score
sever
groin
pain
correl
sever
osteoarthr
conclus
chines
herbal
hgf
therapi
demonstr
benefici
effect
prevent
femor
head
collaps
delay
total
hip
arthroplasti
maintain
physic
function
treatment
steroidassoci
onfh
hgf
therapi
might
therefor
good
altern
treatment
steroidassoci
onfh
secondari
rheumatolog
infect
diseas
coronaviru
diseas
outbreak
remind
us
worldwid
outbreak
sever
acut
respiratori
syndrom
sar
emerg
similarli
specif
therapi
avail
coronaviru
estim
corticosteroid
therapi
administr
patient
higher
percentag
among
sever
diseas
nonsever
diseas
osteonecrosi
pulmonari
fibrosi
depress
commonli
seen
among
convalesc
sar
patient
osteonecrosi
femor
head
onfh
sar
survivor
could
attribut
steroid
high
cumul
dose
steroid
close
associ
occurr
osteonecrosi
steroidassoci
onfh
progress
break
underli
bone
hip
joint
thu
induc
sever
prematur
osteoarthr
hip
would
caus
physic
disabl
sar
survivor
date
treatment
strategi
current
avail
precollaps
steroidassoci
onfh
frequent
name
hippreserv
treatment
abl
complet
stop
rapid
progress
either
collaps
femor
head
hip
osteoarthr
review
pertin
literatur
indic
better
treatment
total
hip
arthroplasti
tha
hip
postcollaps
cours
howev
patient
care
select
tha
limit
implant
lifespan
divers
oper
complic
patient
steroidassoci
onfh
undergon
oper
treatment
disappointingli
metaanalysi
publish
conclud
postmarket
drug
includ
enoxaparin
statin
bisphosphon
iloprost
acetylsalicyl
acid
recommend
diseas
one
reason
singlecompon
drug
fail
take
effect
steroidassoci
onfh
multifactori
diseas
complex
signal
pathway
involv
mechan
explain
fact
individu
continu
longterm
steroid
therapi
develop
steroidassoci
onfh
chines
medicin
may
potenti
solut
steroidassoci
onfh
base
network
pharmacolog
networktarget
multicompon
mechan
china
quit
onfh
patient
undergo
pharmacolog
treatment
especi
treatment
tradit
chines
medicin
tcm
chines
expert
consensu
diagnosi
treatment
osteonecrosi
femor
head
adult
recommend
chines
medicin
one
pharmacolog
treatment
onfh
chines
guidelin
clinic
diagnosi
treatment
femor
head
necrosi
adult
formul
base
evidencebas
medicin
base
version
guidelin
profession
specialist
scholar
orthopaedist
europ
asia
america
china
jointli
develop
new
guidelin
standardis
effect
clinic
diagnosi
treatment
adult
onfh
guidelin
clinic
diagnosi
treatment
osteonecrosi
femor
head
adult
addit
metaanalysi
includ
randomis
control
trial
report
chines
medicin
help
enhanc
effect
core
decompress
surgeri
onfh
howev
therapeut
outcom
chines
medicin
treatment
use
alon
less
investig
report
especi
longterm
followup
studi
lack
huogu
formula
hgf
chines
herbal
medic
commonli
administr
patient
onfh
china
abnorm
lipid
metabol
report
involv
develop
onfh
tcm
theori
believ
phlegmdamp
tan
shi
pathogen
close
associ
abnorm
lipid
metabol
main
tcm
function
hgf
help
invigor
spleen
pi
clear
damp
resolv
phlegm
activ
blood
circul
previou
anim
test
found
allopath
effect
hgf
prevent
steroidtr
anim
develop
steroidassoci
onfh
interestingli
found
hgf
also
help
improv
lipoprotein
metabol
experi
found
ethyl
acet
fraction
hgf
help
inhibit
adipogen
differenti
bone
marrow
stromal
cell
wherea
aqueou
fraction
hgf
promot
osteogen
differenti
conduct
longterm
retrospect
studi
evalu
outcom
hgf
therapi
steroidassoci
onfh
convalesc
sar
patient
averag
year
retrospect
cohort
studi
includ
convalesc
sar
patient
fig
refer
wangj
hospit
confirm
diagnosi
onfh
hospit
total
convalesc
sar
patient
hip
treat
hgf
therapi
alon
patient
exclud
present
studi
clinic
studi
conduct
accord
principl
express
declar
helsinki
approv
institut
review
board
wangj
hospit
patient
consent
particip
studi
diagnosi
onfh
perform
base
distinct
radiograph
featur
seen
magnet
reson
imag
mri
includ
focal
serpentin
low
signal
line
fatti
centr
weight
imag
reactiv
interfac
line
serpigin
peripher
dark
line
inner
bright
line
weight
imag
doubl
line
sign
accord
associ
research
circul
osseou
arco
classif
system
inclus
criteria
convalesc
sar
patient
receiv
steroid
therapi
case
bilater
hip
affect
continu
receiv
oral
hgf
treatment
least
month
confirm
diagnosi
onfh
exclus
criteria
patient
continu
use
steroid
histori
alcohol
histori
hip
injuri
receiv
treatment
onfh
includ
oper
treatment
nonop
treatment
among
patient
nine
male
femal
averag
age
ae
year
rang
year
tabl
patient
bilater
affect
hip
mean
interv
diagnosi
sar
onfh
ae
month
rang
month
accord
arco
classif
hip
classifi
stage
normal
plain
radiograph
specif
osteonecrosi
find
mri
hip
stage
ii
abnorm
plain
radiograph
without
collaps
crescent
sign
nine
hip
stage
iii
abnorm
plain
radiograph
collaps
crescent
sign
four
hip
stage
iv
abnorm
plain
radiograph
hip
arthriti
base
lesion
size
determin
criteria
hip
small
lesion
femor
head
involv
necrot
volum
hip
medium
lesion
hip
larg
lesion
accord
jic
classif
criteria
hip
type
lesion
lesion
occupi
medial
onethird
less
weightbear
portion
hip
type
b
lesion
lesion
occupi
medial
twothird
less
weightbear
portion
hip
type
c
lesion
occupi
medial
twothird
weightbear
portion
patient
follow
till
novemb
receiv
tha
tcm
theori
categoris
corticosteroid
druginduc
pathogen
act
everi
aspect
human
bodi
produc
phlegmdamp
tanshi
pathogen
phlegmdamp
block
meridian
jingluo
induc
qi
stagnat
blood
xue
stasi
believ
patholog
basi
corticosteroidassoci
onfh
phlegmdamp
pathogen
affect
mainli
lower
part
bodi
hip
femor
head
among
suscept
joint
phlegmdamp
pathogen
phlegmdamp
pathogen
affect
femor
head
circul
qi
blood
along
meridian
around
hip
disturb
meridian
branch
pass
femor
head
block
femor
head
lose
nutrit
qi
blood
base
tcm
theori
manag
strategi
tcm
pathogeninduc
disord
includ
clear
damp
resolv
phlegm
activ
blood
circul
implement
manag
strategi
creat
hgf
therapi
hgf
modifi
z
huang
et
al
journal
orthopaed
translat
xxx
xxxx
xxx
linguizhugantang
formula
siwutang
formula
linguizhugantang
formula
commonli
use
clear
damp
resolv
phlegm
main
tcm
function
siwutang
formula
activ
blood
circul
addit
pinellia
rhizoma
praeparatum
fabanxia
radix
salvia
miltiorrhiza
dangshen
strengthen
tcm
function
spleeninvigor
phlegmresolv
wherea
addit
eupolyphaga
steleophaga
cervicornuscolla
lujiaojiao
strengthen
tcm
function
bonetonifi
patient
evenli
given
hgf
treatment
least
month
confirm
diagnosi
onfh
conveni
use
patient
receiv
granul
extract
medic
decoctingfre
chines
herbal
medicin
manufactur
sichuan
neogreen
pharmaceut
technolog
develop
co
ltd
sichuan
chengdu
pr
china
standard
daili
dose
hgf
includ
essenti
compon
extract
follow
crude
drug
tabl
poria
fule
g
cinnamomi
ramulu
guizhi
g
atractylodi
macrocephala
rhizoma
baizhu
g
glycyrrhiza
radix
et
rhizoma
gaocao
g
p
rhizoma
praeparatum
fabanxia
g
radix
salvia
miltiorrhiza
dangshen
g
angelica
sinensi
radix
danggui
g
chuanxiong
rhizom
chuanxiong
g
rehmannia
radix
praeparatum
shudihuang
g
paeonia
radix
rubra
chishao
g
e
steleophaga
tubiechong
g
cervicornuscolla
lujiaojiao
g
hgf
gener
taken
twice
day
meal
patient
also
request
restrict
weightbear
use
two
crutch
year
electron
medic
record
check
make
sure
particip
receiv
homogen
hgf
treatment
routin
outpati
followup
took
place
monthli
hgf
treatment
everi
year
patient
request
return
clinic
develop
relaps
groin
pain
advers
reaction
relat
hgf
treatment
patient
evalu
radiograph
ct
scan
mri
routin
clinic
visit
clinic
inform
also
record
interview
physic
examin
recent
followup
investig
took
place
novemb
everi
patient
invit
complet
questionnair
design
larg
base
harri
hip
score
hh
tabl
co
onfh
walk
function
index
overal
hh
divid
pain
index
physic
function
index
hh
pain
index
classifi
sever
pain
six
grade
hh
physic
function
index
majorli
includ
measur
abil
daili
live
adl
tabl
three
orthopaed
surgeon
specialis
hip
arthriti
involv
present
studi
invit
evalu
imag
decis
made
consensu
among
three
surgeon
collaps
femor
head
defin
fine
radioluc
subchondr
fractur
line
depress
articular
surfac
degre
hip
osteoarthr
measur
accord
kellgrenlawr
kl
classif
tha
endpoint
mean
surviv
time
studi
hip
calcul
use
kaplanmei
method
differ
surviv
distribut
patient
group
differ
arco
stage
test
logrank
test
hh
separ
pain
index
physic
function
index
subindex
also
analys
compar
late
occur
groin
pain
patient
onfh
commonli
ascrib
onfhinduc
osteoarthr
also
analys
correl
degre
pain
degre
osteoarthr
kendal
test
correl
analysi
degre
pain
degre
walk
function
well
correl
degre
osteoarthr
degre
walk
function
conduct
method
spss
version
spss
inc
chicago
il
usa
use
data
process
novemb
patient
provid
complet
data
outcom
measur
final
followup
mean
followup
period
ae
year
rang
year
total
five
patient
convert
tha
sever
hip
osteoarthr
kl
grade
hip
replac
endpoint
mean
hip
surviv
time
without
collaps
year
confid
interv
year
fig
hip
surviv
durat
larg
depend
clinic
stage
convers
rate
tha
patient
arco
stage
iv
wherea
rate
hip
arco
stage
iiii
total
signific
differ
hip
surviv
durat
observ
subgroup
divid
arco
classif
p
logrank
test
fig
harri
hip
score
patient
undergo
tha
recent
followup
examin
show
mean
valu
hh
pain
index
ae
rang
data
indic
patient
reduc
pain
score
patient
commonli
experienc
moder
pain
taken
calcul
method
visual
analog
scale
refer
hand
mean
hh
physic
function
index
ae
rang
indic
patient
maintain
physic
function
overal
mean
hh
ae
rang
analys
hh
five
patient
one
sever
affect
hip
replac
hospit
signific
differ
observ
term
hh
physic
function
index
five
patient
patient
mention
previous
nevertheless
lower
hh
pain
index
total
hh
found
five
patient
p
fig
suggest
patient
bilater
onfh
still
experienc
consider
loss
hip
function
although
alreadi
surgic
replac
sever
side
hip
recent
followup
visit
observ
collaps
femor
head
occur
previous
precollaps
hip
meanwhil
osteoarthr
kl
grade
occur
previous
precollaps
hip
previous
collaps
hip
use
kendal
method
examin
relationship
degre
sever
regard
hip
osteoarthr
pain
physic
function
fig
howev
fail
observ
signific
correl
degre
osteoarthr
degre
hh
pain
index
degre
osteoarthr
degre
walk
function
index
well
degre
hh
pain
index
degre
walk
function
index
fig
also
observ
four
patient
without
osteoarthr
kl
grade
complain
chronic
moder
hip
pain
two
patient
doubt
hip
osteoarthr
kl
grade
complain
chronic
intens
hip
pain
data
indic
osteoarthr
could
fulli
explain
sourc
pain
factor
might
also
involv
caus
pain
patient
hgf
demonstr
promis
effect
treatment
steroidassoci
onfh
among
convalesc
sar
patient
longterm
outcom
remain
uncertain
retrospect
cohort
studi
aim
evalu
longterm
outcom
hgf
therapi
uniqu
patient
novemb
five
patient
subject
tha
tha
studi
endpoint
surviv
analysi
predict
mean
hip
surviv
time
would
year
patient
steroidassoci
onfh
simultan
suffer
rheumatolog
diseas
necessit
continu
corticosteroid
therapi
use
corticosteroid
made
difficult
assess
real
effect
medic
intervent
onfh
convalesc
sar
patient
homogen
special
group
patient
observ
effect
medic
intervent
steroidassoci
onfh
one
hand
sar
seem
connect
develop
onfh
hand
convalesc
sar
patient
need
restart
corticosteroid
therapi
effect
hgf
would
interf
capac
prevent
femor
head
collaps
major
index
evalu
effect
medic
intervent
precollaps
onfh
present
studi
observ
new
collaps
case
patient
precollaps
onfh
accord
systemat
review
publish
studi
natur
histori
hip
onfh
overal
collaps
rate
mean
followup
durat
year
wei
et
al
report
collaps
rate
patient
receiv
oral
administr
huo
xue
tong
luo
capsul
chines
medic
mean
followup
durat
year
result
consist
support
wei
find
chines
medicin
help
prevent
progress
femor
head
collaps
avoid
tha
prolong
followup
data
goal
hippreserv
treatment
avoid
delay
tha
also
maintain
restor
physic
function
hip
joint
hh
outcom
measur
frequent
use
evalu
physic
function
among
patient
hip
joint
disord
observ
mean
hh
ae
patient
without
tha
end
present
studi
although
data
suggest
hgf
therapi
yield
poor
result
hh
data
still
compar
previou
relev
studi
alendron
one
commonli
use
pharmacolog
treatment
onfh
rct
studi
includ
patient
receiv
alendron
treatment
report
mean
hh
ae
followup
durat
year
howev
efficaci
alendron
treat
onfh
question
later
studi
core
decompress
believ
reliabl
oper
treatment
precollaps
onfh
even
rct
studi
publish
report
mean
hh
ae
patient
undergon
core
decompress
surgeri
year
followup
visit
present
studi
separ
origin
hh
pain
index
physic
function
index
latter
evalu
divers
adl
includ
need
walk
aid
distanc
walk
limp
wear
shoe
sock
climb
stair
public
transport
sit
rang
motion
moreov
observ
patient
without
tha
maintain
aforement
adl
mean
followup
durat
year
rate
method
hh
physic
function
index
onfh
caus
rapidli
worsen
hip
osteoarthr
believ
sourc
groin
pain
reduc
physic
function
although
observ
high
morbid
osteoarthr
studi
cohort
sever
pain
proport
sever
osteoarthr
record
four
patient
without
hip
osteoarthr
complain
moder
groin
pain
two
patient
doubt
hip
osteoarthr
complain
intens
groin
pain
chronic
pain
complex
subject
sensori
emot
experi
psychobehaviour
problem
uncommon
among
special
patient
daringli
hypothesis
inexplic
groin
pain
somewhat
ascrib
chronic
pain
sensitis
depress
signific
limit
studi
lack
sar
patient
without
medic
intervent
control
howev
still
treatmentasusu
avail
would
ethic
give
placebo
treatment
well
similar
studi
report
combin
vasoact
pharmacotherapi
could
success
prevent
collaps
studi
includ
four
sar
patient
hand
randomis
clinic
trial
concern
onfh
follow
long
term
publish
studi
mostli
report
result
followup
durat
year
previou
studi
report
interv
diagnosi
collaps
could
year
case
comparison
natur
collaps
rate
report
systemat
review
includ
hip
onfh
studi
observ
collaps
rate
base
prolong
followup
data
support
hgf
help
prevent
natur
diseas
progress
onfh
best
knowledg
first
studi
address
longestterm
outcom
chines
medicin
therapi
steroidassoci
onfh
result
followup
studi
support
role
hgf
spleeninvigor
chines
herbal
medic
treatment
steroidassoci
onfh
defer
time
tha
prevent
progress
femor
head
collaps
maintain
physic
function
despit
longterm
observ
support
high
morbid
hip
osteoarthr
patient
experienc
inexplic
groin
pain
correl
sever
hip
osteoarthr
nevertheless
hgf
consid
effect
therapeut
option
steroidassoci
onfh
studi
support
grant
twelfth
fiveyear
nation
scienc
technolog
support
program
nation
natur
scienc
foundat
china
inform
consent
obtain
individu
particip
includ
studi
raw
data
gener
wangj
hospit
deriv
data
support
find
studi
avail
correspond
author
request
